| Dr Nader R Mohtadi, MD | |
|
5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 | |
| (734) 712-8350 | |
| (734) 712-8351 |
| Full Name | Dr Nader R Mohtadi |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 5333 Mcauley Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184689143 | NPI | - | NPPES |
| 3516137 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301055978 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huron Valley Radiology Pc | 2961466859 | 72 |
News Archive
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
Bruker Corporation today announced the closing of its acquisition of the Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses from Veeco Instruments, Inc. for $229.4 million in cash.
The shoulder is the most commonly dislocated joint in the human body, occurring most often in young, athletic people. New research from the University of Michigan Health System shows patients who have recurrent shoulder dislocations may benefit from surgical reconstruction using cadaver bone and cartilage to essentially 'sculpt' a new shoulder.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Humana has served nutritious meals to more than 81,000 Humana Medicare Advantage members in 120 cities after a hospital or nursing facility stay since the company's meal-delivery program began in 2006. Yesterday, Well Dine delivered the Humana program's one millionth meal to Humana Medicare Advantage member Sylvia van Dyke, 61, of Knoxville.
› Verified 3 days ago
| Entity Name | Huron Valley Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659398519 PECOS PAC ID: 2961466859 Enrollment ID: O20041119000401 |
News Archive
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
Bruker Corporation today announced the closing of its acquisition of the Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses from Veeco Instruments, Inc. for $229.4 million in cash.
The shoulder is the most commonly dislocated joint in the human body, occurring most often in young, athletic people. New research from the University of Michigan Health System shows patients who have recurrent shoulder dislocations may benefit from surgical reconstruction using cadaver bone and cartilage to essentially 'sculpt' a new shoulder.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Humana has served nutritious meals to more than 81,000 Humana Medicare Advantage members in 120 cities after a hospital or nursing facility stay since the company's meal-delivery program began in 2006. Yesterday, Well Dine delivered the Humana program's one millionth meal to Humana Medicare Advantage member Sylvia van Dyke, 61, of Knoxville.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nader R Mohtadi, MD 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 Ph: (734) 712-8350 | Dr Nader R Mohtadi, MD 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 Ph: (734) 712-8350 |
News Archive
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
Bruker Corporation today announced the closing of its acquisition of the Atomic Force Microscopy (AFM) and the Optical Industrial Metrology (OIM) instruments businesses from Veeco Instruments, Inc. for $229.4 million in cash.
The shoulder is the most commonly dislocated joint in the human body, occurring most often in young, athletic people. New research from the University of Michigan Health System shows patients who have recurrent shoulder dislocations may benefit from surgical reconstruction using cadaver bone and cartilage to essentially 'sculpt' a new shoulder.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
Humana has served nutritious meals to more than 81,000 Humana Medicare Advantage members in 120 cities after a hospital or nursing facility stay since the company's meal-delivery program began in 2006. Yesterday, Well Dine delivered the Humana program's one millionth meal to Humana Medicare Advantage member Sylvia van Dyke, 61, of Knoxville.
› Verified 3 days ago
Dr. Vishal Bhagat, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Dr. Gil S. Borlaza, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Oneil Lee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Owen Stark, Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8251 | |
Dr. Atif Siddiqi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Dr. Eva Bieniek, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-3456 Fax: 734-712-3456 | |
Paul Lee, Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 |